Skip to main navigation Skip to search Skip to main content

Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial

  • Pasi A. Jänne
  • , Xiaofei Wang
  • , Mark A. Socinski
  • , Jeffrey Crawford
  • , Thomas E. Stinchcombe
  • , Lin Gu
  • , Marzia Capelletti
  • , Martin J. Edelman
  • , Miguel A. Villalona-Calero
  • , Robert Kratzke
  • , Everett E. Vokes
  • , Vincent A. Miller
  • Brigham and Women's Hospital
  • Duke University
  • University of North Carolina at Chapel Hill
  • University of Maryland
  • Ohio State University
  • University of Minnesota Twin Cities
  • University of Chicago
  • Memorial Sloan-Kettering Cancer Center

Research output: Contribution to journal › Article › peer-review

209 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science